Microbot Medical Inc.

NASDAQ: MBOT · Real-Time Price · USD
2.65
0.08 (3.11%)
At close: May 23, 2025, 3:59 PM
2.67
0.56%
After-hours: May 23, 2025, 07:53 PM EDT

Company Description

Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space.

The company, through its ViRob, TipCAT, CardioSert, and Liberty micro-robotic technologies, developing Self Cleaning Shunt for the treatment of hydrocephalus and normal pressure hydrocephalus; a disposable robot for various endovascular interventional procedures; and a multi generation pipeline portfolio.

It has 42 issued/allowed patents and 23 patent applications pending worldwide.

The company has a strategic collaboration agreement with Stryker Corporation for technology co-development.

Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts.

Microbot Medical Inc.
Microbot Medical Inc. logo
Country United States
IPO Date Mar 25, 1992
Industry Medical - Instruments & Supplies
Sector Healthcare
Employees 20
CEO Harel Gadot

Contact Details

Address:
25 Recreation Park Drive
Hingham, Massachusetts
United States
Website https://www.microbotmedical.com

Stock Details

Ticker Symbol MBOT
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0000883975
CUSIP Number 59503A204
ISIN Number US59503A2042
Employer ID 94-3078125
SIC Code 2836

Key Executives

Name Position
Harel Gadot Co-Founder, President, Chief Executive Officer & Chairman
Dr. Simon Sharon MBA, MSc Chief Technology Officer & GM of Microbot Israel
Rachel Vaknin Chief Financial Officer
Dr. Juan Diaz-Cartelle Chief Medical Officer
Michal Ahuvia Director of Operations
Naama Moav Vice President of Human Resources
Paul Mullen Vice President of Sales

Latest SEC Filings

Date Type Title
May 14, 2025 10-Q Quarterly Report
May 12, 2025 SCHEDULE 13G/A [Amend] Filing
May 09, 2025 SCHEDULE 13G/A [Amend] Filing
Apr 30, 2025 8-K Current Report
Apr 29, 2025 DEF 14A Filing
Apr 29, 2025 ARS Filing
Apr 29, 2025 DEFA14A Filing
Apr 23, 2025 8-K Current Report
Apr 17, 2025 PRE 14A Filing
Apr 17, 2025 8-K Current Report